Lisa A. Robinson

Lisa A. Robinson is Deputy Director of the Center for Health Decision Science and a senior research scientist at the Center for Health Decision Science and Center for Risk Analysis at the Harvard T.H. Chan School of Public Health.

Promoting Best Practices for U.S. Regulatory Analysis

Promoting Best Practices for U.S. Regulatory Analysis

Benefit-cost analysis experts advocate changes to a draft update of OMB Circular A-4.

COVID-19 and Uncertainties in the Value Per Statistical Life

COVID-19 and Uncertainties in the Value Per Statistical Life

Uncertainties in value per statistical life estimates impact the extent to which COVID-19 policies yield net benefits.

Regulating Cost-Benefit Analysis

Regulating Cost-Benefit Analysis

EPA’s advance notice raises fundamental questions about how the agency should weigh costs and benefits.

Regulatory Analysis Under the Trump Administration

Regulatory Analysis Under the Trump Administration

Deregulatory executive orders require a new approach to analyzing regulatory impact.

Are We Making Progress in Valuing Health and Longevity in Regulatory Analysis?

Are We Making Progress in Valuing Health and Longevity in Regulatory Analysis?

Although agencies have made strides concerning values for mortality risk reductions, more research is needed on these values.

New Recommendations for Valuing Mortality Risk Reductions

New Recommendations for Valuing Mortality Risk Reductions

EPA’s Science Advisory Board offers recommendations to improve cost-benefit analysis.